HIV-associated primary cutaneous anaplastic large cell lymphoma: a clinicopathological subset with more aggressive behavior? Case report and review of the literature

J Cutan Pathol. 2012 Dec;39(12):1100-9. doi: 10.1111/cup.12020. Epub 2012 Oct 13.

Abstract

Human immunodeficiency virus (HIV)-infected patients carry an increased risk of lymphomagenesis. Although the majority of HIV-related lymphomas have a B-cell phenotype, the incidence of peripheral T-cell lymphomas (PTCL), including primary cutaneous subtypes, may be up to 15-fold higher than in the general population, with anaplastic large cell lymphomas (ALCL) accounting for 18-28% of HIV-associated PTCL. In contrast to systemic ALCL, the relation between HIV infection and primary cutaneous ALCL has been relatively neglected in the literature. We report the case of a primary cutaneous ALCL occurring in a 76-year-old patient with advanced HIV infection, and showing unusually aggressive course. Neither ALK1 immunohistochemical positivity nor evidence of EBV infection were detected; staging procedures at initial presentation ruled out systemic involvement. We provide a summary of the literature regarding primary cutaneous ALCL in HIV-infected patients. We draw attention to clinicopathological features, prognostic implications and therapeutic quandaries of HIV-related primary cutaneous ALCL. Further, we propose that a significant fraction of HIV-associated cases might represent a more aggressive subset of primary cutaneous ALCL.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antigens, CD / metabolism
  • Biomarkers, Tumor / metabolism
  • Fatal Outcome
  • HIV Infections / complications*
  • HIV Infections / metabolism
  • Homosexuality, Male
  • Humans
  • Lymphoma, AIDS-Related / metabolism
  • Lymphoma, AIDS-Related / pathology*
  • Lymphoma, AIDS-Related / virology
  • Lymphoma, Large-Cell, Anaplastic / metabolism
  • Lymphoma, Large-Cell, Anaplastic / pathology*
  • Lymphoma, Large-Cell, Anaplastic / virology
  • Male
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology*
  • Skin Neoplasms / virology

Substances

  • Antigens, CD
  • Biomarkers, Tumor